Literature DB >> 33804551

Role of TNF-α-Inducing Protein Secreted by Helicobacter pylori as a Tumor Promoter in Gastric Cancer and Emerging Preventive Strategies.

Masami Suganuma1, Tatsuro Watanabe2, Eisaburo Sueoka3, In Kyoung Lim4, Hirota Fujiki3.   

Abstract

The tumor necrosis factor-α (TNF-α)-inducing protein (tipα) gene family, comprising Helicobacter pylori membrane protein 1 (hp-mp1) and tipα, has been identified as a tumor promoter, contributing to H. pylori carcinogenicity. Tipα is a unique H. pylori protein with no similarity to other pathogenicity factors, CagA, VacA, and urease. American H. pylori strains cause human gastric cancer, whereas African strains cause gastritis. The presence of Tipα in American and Euro-Asian strains suggests its involvement in human gastric cancer development. Tipα secreted from H. pylori stimulates gastric cancer development by inducing TNF-α, an endogenous tumor promoter, through its interaction with nucleolin, a Tipα receptor. This review covers the following topics: tumor-promoting activity of the Tipα family members HP-MP1 and Tipα, the mechanism underlying this activity of Tipα via binding to the cell-surface receptor, nucleolin, the crystal structure of rdel-Tipα and N-terminal truncated rTipα, inhibition of Tipα-associated gastric carcinogenesis by tumor suppressor B-cell translocation gene 2 (BTG2/TIS21), and new strategies to prevent and treat gastric cancer. Thus, Tipα contributes to the carcinogenicity of H. pylori by a mechanism that differs from those of CagA and VacA.

Entities:  

Keywords:  EMT; HP-MP1; TNF-α; Tipα; gastric cancer; nucleolin

Year:  2021        PMID: 33804551      PMCID: PMC7999756          DOI: 10.3390/toxins13030181

Source DB:  PubMed          Journal:  Toxins (Basel)        ISSN: 2072-6651            Impact factor:   4.546


  57 in total

1.  Helicobacter pylori infection and gastric cancer.

Authors:  Pelayo Correa
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2003-03       Impact factor: 4.254

2.  The complete genome sequence of the gastric pathogen Helicobacter pylori.

Authors:  J F Tomb; O White; A R Kerlavage; R A Clayton; G G Sutton; R D Fleischmann; K A Ketchum; H P Klenk; S Gill; B A Dougherty; K Nelson; J Quackenbush; L Zhou; E F Kirkness; S Peterson; B Loftus; D Richardson; R Dodson; H G Khalak; A Glodek; K McKenney; L M Fitzegerald; N Lee; M D Adams; E K Hickey; D E Berg; J D Gocayne; T R Utterback; J D Peterson; J M Kelley; M D Cotton; J M Weidman; C Fujii; C Bowman; L Watthey; E Wallin; W S Hayes; M Borodovsky; P D Karp; H O Smith; C M Fraser; J C Venter
Journal:  Nature       Date:  1997-08-07       Impact factor: 49.962

3.  Structures of the tumor necrosis factor alpha inducing protein Tipalpha: a novel virulence factor from Helicobacter pylori.

Authors:  Tommaso Tosi; Gianluca Cioci; Karina Jouravleva; Cyril Dian; Laurent Terradot
Journal:  FEBS Lett       Date:  2009-05-04       Impact factor: 4.124

4.  High prevalence of the CagA-positive Helicobacter pylori strains in Japanese asymptomatic patients and gastric cancer patients.

Authors:  T Shimoyama; S Fukuda; M Tanaka; T Mikami; Y Saito; A Munakata
Journal:  Scand J Gastroenterol       Date:  1997-05       Impact factor: 2.423

5.  Helicobacter pylori membrane protein 1: a new carcinogenic factor of Helicobacter pylori.

Authors:  M Suganuma; M Kurusu; S Okabe; N Sueoka; M Yoshida; Y Wakatsuki; H Fujiki
Journal:  Cancer Res       Date:  2001-09-01       Impact factor: 12.701

6.  Helicobacter pylori-secreting protein Tipalpha is a potent inducer of chemokine gene expressions in stomach cancer cells.

Authors:  Takashi Kuzuhara; Masami Suganuma; Miki Kurusu; Hirota Fujiki
Journal:  J Cancer Res Clin Oncol       Date:  2006-11-25       Impact factor: 4.553

Review 7.  Carcinogenic role of tumor necrosis factor-alpha inducing protein of Helicobacter pylori in human stomach.

Authors:  Masami Suganuma; Takashi Kuzuhara; Kensei Yamaguchi; Hirota Fujiki
Journal:  J Biochem Mol Biol       Date:  2006-01-31

8.  Development of Helicobacter pylori-induced gastric carcinoma in Mongolian gerbils.

Authors:  S Honda; T Fujioka; M Tokieda; R Satoh; A Nishizono; M Nasu
Journal:  Cancer Res       Date:  1998-10-01       Impact factor: 12.701

9.  TIS21 negatively regulates hepatocarcinogenesis by disruption of cyclin B1-Forkhead box M1 regulation loop.

Authors:  Tae Jun Park; Ji Yeon Kim; S Paul Oh; So Young Kang; Bong Wan Kim; Hee Jung Wang; Kye Yong Song; Hyoung Chin Kim; In Kyoung Lim
Journal:  Hepatology       Date:  2008-05       Impact factor: 17.425

10.  KRAS4A directly regulates hexokinase 1.

Authors:  Caroline R Amendola; James P Mahaffey; Seth J Parker; Ian M Ahearn; Wei-Ching Chen; Mo Zhou; Helen Court; Jie Shi; Sebastian L Mendoza; Michael J Morten; Eli Rothenberg; Eyal Gottlieb; Youssef Z Wadghiri; Richard Possemato; Stevan R Hubbard; Allan Balmain; Alec C Kimmelman; Mark R Philips
Journal:  Nature       Date:  2019-12-11       Impact factor: 49.962

View more
  4 in total

Review 1.  Nucleolin: a cell portal for viruses, bacteria, and toxins.

Authors:  Fiorella Tonello; Maria Lina Massimino; Caterina Peggion
Journal:  Cell Mol Life Sci       Date:  2022-05-03       Impact factor: 9.207

2.  Systems pharmacology to reveal multi-scale mechanisms of traditional Chinese medicine for gastric cancer.

Authors:  Lulu Zhang; Yue Xiao; Ruijie Yang; Siyi Wang; ShuangXin Ma; Jianling Liu; Wei Xiao; Yonghua Wang
Journal:  Sci Rep       Date:  2021-11-12       Impact factor: 4.379

Review 3.  Old and New Aspects of H. pylori-Associated Inflammation and Gastric Cancer.

Authors:  Andreea Ligia Dincă; Lorena Elena Meliț; Cristina Oana Mărginean
Journal:  Children (Basel)       Date:  2022-07-20

Review 4.  Peripheral Cytokine Levels as a Prognostic Indicator in Gastric Cancer: A Review of Existing Literature.

Authors:  Elton Yang; Wei Chua; Weng Ng; Tara Laurine Roberts
Journal:  Biomedicines       Date:  2021-12-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.